Member Info for Compoundinterest

Wyn- Just observing the 1 day/1week RSI and it seems to tick back down to 60.. despite it being all time highs.. really strange. Does that mean further upward potential. However, the yearly RSI is 80+ which is no surprise. Not sure how you would interpret this is meaningful at all? Thought it's quite interesting. Would be great to learn your valued input from a TA perspective :) GL mate.

Looks like I'll be sitting on the sidelines for a while until the storm is over. GLA

Nice steady continued momentum! Onwards and upwards.

Besides Evgen, what other drugs could Boris be referring to that is a pill and also in the clinic for Covid-19?

Fascinating.. if it were true that SFX-01 is effective. I think Mr Richard Griffins would be kicking himself for selling.

"Proposed equity raise in the range of £190m to £240m, expected in the coming weeks" -

What does that mean for shareholders? I hope that does not mean wiping out shareholder value... since market cap is only around 150m... a debt for equity swap would significantly dilute this company estimating 60-80%...? Any analysis pls.

Topped up on retrace before closing. I think this should be quite sticky for many holders since we all see the potential value of such an easily understood game changing product! So I think the trend is heading upwards. Really really excited about this company.

In the RNS on April 18th "In addition, Kier is continuing to consider a potential equity raise." If an. RI seems unlikely, how do you explain this Metamorphosis84? They have said RI is being considered repeatedly now.

Yes DD77- similar companies doing the same are 50x more valuable but doing very similar things. Can have a look at Recursion pharmaceuticals recently listed on Nasdaq valued at 5bn... C4x discovery has legs but doesn't quite get the same attention like they do across the pond. In addition, it would require a bit more investment to further develop new pipeline especially after a pretty substantial and successful out licensing agreement for IL17 and Orexin

Interesting, hopefully it defies the laws of RSI gravity then haha! GL.

Thanks for sharing your valuable opinion. RSI looks like hitting 80-90... on a day to week view on HL. From your previous mentions on Eve, that indicates the charts this looks quite frothy... keen to find a "good" entry point but just unsure how long this price action can continue before it retreats.. exciting times for the company tho and plenty of news in the pipeline.

Now waiting for the rights issue to be sorted and this can turnaround. Hopefully we can hear more about this on 21st April.

wyndrum - nice to see you on this board too. Fascinated to learn your view from a TA perspective now? It's been a fantastic ride up these few trading days...

Complex business requires simplification. Focus on profits rather than big sales on slim margins.
- identified impairments and charges totalling approximately £1.7 billion
- expected to result in an ongoing reduction in operating profit of approximately £30 million each year
-Net debt £750 million
- Without the need for an equity issue

Finally... what we've all been waiting for.

Great find! Thanks for sharing. The results further strengthen the work Evgen is doing. Considering it's the only patented drugable option currently in trials? It's potential worth seems significant if demonstrate efficacy against Covid. It helps that the research was from John Hopkins University... couldn't get anymore prestigious than that.

With multiple shots at goal, a licensing deal on any indication would be be nice and will further de-risks my investment and increase the value of this company significantly IMO. With the new appointment, this should accelerate this Hwu's strategy more quickly. Hoping discussions with big pharma are advancing for the promising pipelines. GLA.

Interesting... its now below the 8p placing and still continued selling pressure. Not sure sure where the source is from but it seems the supply has been continuous and flooded the market for several months now causing gradual SP decline.

Not so sure if Griffiths still have holdings under 3% outstanding. Also whether any outstanding residue for TS Capital's 5,078,334 3.7% and Mercia Fund Mgrs 5,913,818 4.3%. - just hoping the supply of selling is out of steam so we can finally see stability and upward momentum... I've timed this completely wrong.. should have waited a bit longer for entry.

Thanks for ur input OnTarget. Would be interesting to calculate the difference between those In Verus Out to calculate the total overhang; just looking at the shareholders list seems more sold and did not subscribe fully. My brief estimates are total shares floating 270million verus 110million held be IIs on that list; so difference 160million held by smaller investors or sellers.

Compared to previously, the following investors are no longer on the list:
OUT: Richard Griffins out, Mercia Fund, TS Capital
IN: Octopus, Chelverton, RAB CAPITAL